Laboratoires Thea
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
4
Ending by 2030
May 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Mar 24, 2027The maintenance fee for Oligonucleotide therapy for leber congenital amaurosis (US 10,421,963) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
- 1 fee due May 3, 2027The maintenance fee for Liquid receiving bottle with drop by drop dispensing head (US 9,174,777) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.
- 1 fee due Sep 5, 2027The maintenance fee for Oligonucleotide therapy for Leber congenital amaurosis (US 11,920,132) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
- 1 fee due Oct 7, 2027The maintenance fee for Antisense oligonucleotides for the treatment of eye disease (US 10,612,025) comes due Oct 7, 2027. Unpaid by Apr 7, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,289,399 | Ophthalmologic compositions and use mode thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 7,971,755 | Container for packaging a liquid to be dispensed in drops, reversibly deformed by air input In force · From the USPTO record | In force | From the USPTO record | |
| US 9,402,765 | Bottle for packaging liquid that is to be dispensed drop by drop, with antibacterial protection In force · From the USPTO record | In force | From the USPTO record | |
| US 8,894,622 | Bottle for packaging liquid that is to be dispensed drop by drop, with antibacterial protection In force · From the USPTO record | In force | From the USPTO record | |
| US 9,174,777 | Liquid receiving bottle with drop by drop dispensing head In force · From the USPTO record | In force | From the USPTO record | |
| US 8,772,337 | Preservative-free prostaglandin-based ophthalmic solution In force · From the USPTO record | In force | From the USPTO record | |
| US 8,637,054 | Polymeric Delivery System for a Nonviscous Prostaglandin-Based Solution Without Preservatives In force · High confidence | In force | High confidence | |
| US 8,690,019 | Head For Dispensing A Liquid As A Drip In force · High confidence | In force | High confidence | |
| US 8,969,305 | Aqueous Ophthalmic Solution Based on Cyclosporin In force · High confidence | In force | High confidence | |
| US 9,487,339 | Liquid dispensing head, in particular for a bottle for packaging a liquid to be dispensed drop by drop In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 21: 1 patent in force now held by others · 1 lapsed for an unpaid fee · 6 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 pending · 2 abandoned · 1 no status recorded